10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001144204-17-040380`
Period End Date	20170630
Filing Date	20170803
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	iova-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 42 Income Statement 36 Cash Flow Statement 56 Comprehensive Income 12

Balance Sheet 42 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.59M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.72M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$120.97M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$114.28M	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesCurrent`	$59.75M	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesCurrent`	$14.73M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.04M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.42M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$135.43M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$169.51M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.58M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.37M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Total Assets	`Assets`	$138.01M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	62.25M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	62.68M	shares	Point-in-time
Total Assets	`Assets`	$171.89M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	62.25M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	62.68M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.69M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$863.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.11M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.17M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$4.97M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$8.86M	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 62,680,390 and 62,248,074 shares issued and outstanding as of June 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 62,680,390 and 62,248,074 shares issued and outstanding as of June 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$323.99M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$330.32M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$29.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-201.18M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-157.12M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$129.15M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$166.92M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$171.89M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$138.01M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	-	USD	1 Quarter
Revenues	`Revenues`	-	USD	1 Quarter
Revenues	`Revenues`	-	USD	2 Qtrs
Revenues	`Revenues`	-	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$8.65M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$36.28M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$19.65M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.46M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$10.08M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$7.26M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.19M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.93M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$11.73M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$23.58M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$44.46M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$18.74M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-18.74M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-44.46M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-11.73M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-23.58M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$204.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$403.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$290.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$164.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-23.38M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-11.56M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-18.45M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-44.06M	USD	2 Qtrs
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.23	USD	1 Quarter
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.37	USD	2 Qtrs
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.71	USD	2 Qtrs
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.37	USD	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	62,457.00	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	62,371.00	shares	2 Qtrs
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	51,082.00	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	49,807.00	shares	2 Qtrs

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-23.38M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-18.45M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-44.06M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$540.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$464.00K	USD	2 Qtrs
Amortization of premium on investments	`AmortizationOfDebtDiscountPremium`	$37.00K	USD	2 Qtrs
Amortization of premium on investments	`AmortizationOfDebtDiscountPremium`	-	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$6.59M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$3.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$4.60M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$7.14M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$505.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.38M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-233.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.99M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.06M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$3.21M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-36.30M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-8.30M	USD	2 Qtrs
Purchase of short- term investments	`PaymentsToAcquireAvailableForSaleSecurities`	-	USD	2 Qtrs
Purchase of short- term investments	`PaymentsToAcquireAvailableForSaleSecurities`	$68.34M	USD	2 Qtrs
Maturities of short- term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$67.88M	USD	2 Qtrs
Maturities of short- term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$44.95M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$823.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$56.00K	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$44.13M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-515.00K	USD	2 Qtrs
Tax payments related to shares witheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.16M	USD	2 Qtrs
Tax payments related to shares witheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$349.00K	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$250.00K	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$621.00K	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$237.00K	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$646.00K	USD	2 Qtrs
Proceeds from the issuance of preferred stock and common stock, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from the issuance of preferred stock and common stock, net	`ProceedsFromIssuanceOfCommonStock`	$95.69M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-265.00K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$96.19M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$7.57M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$87.38M	USD	2 Qtrs
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$33.59M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$106.72M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$120.97M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$114.28M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$33.59M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$106.72M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$120.97M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$114.28M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Interest paid	`InterestPaidNet`	-	USD	2 Qtrs
Interest paid	`InterestPaidNet`	-	USD	2 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnShorttermInvestments`	$-29.00K	USD	2 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnShorttermInvestments`	$30.00K	USD	2 Qtrs
Acquisitions of property and equipment under accounts payable	`LeaseholdImprovementsPaidByLandlord`	$-155.00K	USD	2 Qtrs
Acquisitions of property and equipment under accounts payable	`LeaseholdImprovementsPaidByLandlord`	-	USD	2 Qtrs

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-23.38M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-11.56M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-18.45M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-44.06M	USD	2 Qtrs
Unrealized (loss) gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$10.00K	USD	1 Quarter
Unrealized (loss) gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-29.00K	USD	2 Qtrs
Unrealized (loss) gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$30.00K	USD	2 Qtrs
Unrealized (loss) gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-11.55M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-23.38M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-18.42M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-44.09M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.